Gao YT, et al. Sci China Chem September (2013) Vol.56 No.9
1207
methane and water. The organic layer was dried over mag-
nesium sulfate and filtered. The solvent was removed to
give a yellow oily 3a in quantitative yield. The compound
was used without further purification. Dissolving 3a to 20
mL DMF to make a 0.5 mmol/L solution.
and extracted with dichloromethane/brine. The dichloro-
methane was removed by rotary evaporator. The residue
was purified by chromatography on silica (petroleum
ether/dichloromethane, v/v = 4/1) to afford the product as a
yellow powder (300 mg, yield: 19%). 1H NMR (400 MHz,
CDCl3) δ (TMS, ppm): 9.82 (s, 1H), 7.70 (d, J = 8.7 Hz,
2H), 7.47 (d, J = 8.5 Hz, 4H), 7.29 (s, 2H), 7.25 (s, 4H),
7.18 (d, J = 7.7 Hz, 9H), 7.13–7.02 (m,13H), 6.66 (d, J =
3.9 Hz, 2H). 13C NMR (CDCl3, 100 MHz) δ (TMS, ppm):
190.39, 152.72, 151.01, 147.66, 144.75, 137.14, 131.34,
129.62, 128.21, 126.31, 126.19, 123.16, 122.66, 121.79,
121.62, 120.14.
5-(N,N-Bis(4-tert-Octylphenyl)amino)-2-(tri-n-butylstannyl)-
thiophene (3b)
A modified version of a previously reported method was
used [18]. A solution of n-BuLi (5.6 mL, 9.0 mmol, 1.6 M
in hexane) was added to a solution of 2b (3.3 g, 6.9 mmol)
in 40 mL of THF at 78 °C. The solution was stirred for 30
min, then slowly warmed to room temperature over 30 min,
and stirred for another 30 min. The mixture was cooled to
78 °C again, and 2.42 mL (9.0 mmol) of tri-n-butyl-
chlorostannane was added. After that the mixture was
stirred for 30 min at the same condition. The mixture was
then warmed to room temperature and stirred for 16 h. The
mixture was quenched with water (2 mL) and extracted with
dichloromethane/water. The organic layer was dried over
magnesium sulfate and filtered. The solvent was removed to
give a yellow oily 3b in quantitative yield. The compound
was used without further purification. Dissolving 3b to 13.8
ml DMF to make it 0.3 mmol/L in DMF.
4-[N,N-Bis(5-(N,N-bis(4-tert-octylphenyl)amino)-2-thienyl)-
amino]benzaldehyde (5b)
In a 100 mL two-neck round-bottom flask, 1 (0.79 g , 1.5
mmol), PdCl2(PPh3)2 (24 mg, 0.034 mmol) were dissolved
in 34 mL dry DMF. The mixture was heated to 50 °C. 3b
(6.0 mL, 3.0 mmol) diluted by DMF was added. The solu-
tion was slowly warmed to 80 °C and stirred for 1 h. The
mixture was stirred for an additional 16 h at 60 °C. After
cooling, the mixture was quenched with water (2 mL) and
extracted with dichloromethane/brine. The dichloromethane
was removed by rotary evaporator. The residue was purified
by column chromatography on silica (petroleum ether:
dichloromethane, v/v = 4:1) to afford the product as a yel-
(4,4',4''-(1,3,5-Triazine-2,4,6-triyl)tris(benzene-4,1-diyl))-
1
low powder (350 mg, yield: 19%). H NMR (400 MHz,
tris(methylene)triphosphonate (4)
THF) δ (TMS, ppm): 9.69 (s, 1H), 7.59 (d, J = 8.7 Hz, 2H),
7.40 (d, J = 8.6 Hz, 4H), 7.19 (d, J = 8.7 Hz, 8H), 7.09–6.87
(m, 16H), 6.46 (d, J = 3.9 Hz, 2H), 1.65 (s, 8H), 1.26 (s,
24H), 0.66 (s, 36H). 13C NMR (100 MHz, THF) δ (TMS,
ppm): 192.53, 156.11, 155.31, 148.89, 148.55, 148.24,
139.81, 135.12, 134.33, 134.03, 130.43, 129.67, 129.61,
125.60, 125.18, 124.06, 123.83, 60.47, 41.59, 35.73, 34.90,
34.66.
In a 100 mL round- bottom flask, 2,4,6-tri (p-tolyl)-1,3,5-
triazine (3.51 g, 0.01 mol), NBS (5.34 g 0.03 mol) and BPO
(0.3 g, 1.2 mmol) were dissolved into 50 mL chlorobenzene
and heated at 110 °C for 7 h. The mixture was filtered and
the solvent was removed under vacuum. The residue was
dissolved into trimethyl phosphite (10 mL) and refluxed for
9 h. The excessive trimethyl phosphite was removed under
vacuum. The residue was purified by column chromatog-
raphy on silica (ethanol/dichloromethane, v/v = 1/10) to
afford the product as a white powder (5.3 g, yield: 78 %).
1H NMR (CDCl3, 400 MHz), δ (TMS, ppm): 8.71 (d, 6H, J
= 8.0 Hz), 7.51 (m, 6H), 3.61 (d, 18H, J = 10.8 Hz), 3.30 (d,
6H, J = 22.0 Hz). 13C NMR (CDCl3, 100 MHz), δ (TMS,
ppm): 171.3, 136.3, 136.2, 135.0, 130.1, 129.3, 129.2, 53.1,
53.0, 33.9, 32.5. HRMS (EI) m/z: Calcd. for C30H36N3O9P3:
675.1664, Found: 675.1663.
2,4,6-Tris[(4-(N,N-Bis(5-(N,N-diphenylamino)-2-thienyl)
amino))(benzene-4,1-diyl)(ethene-2,1-diyl)(benzene-4,1-diyl))]-
1,3,5-triazine (STAPA-a)
In a 100 mL two-neck round-bottom flask were added 4
(33.78 mg, 0.05 mmol), 5a (154.4 mg, 0.20 mmol),
potassium tert-butoxide (112.0 mg, 1.0 mmol), 18-crown-6
(10 mg, 0.04 mmol), and 40 mL DCM under argon
atmosphere. After stirring at 45 °C for 6 h, the mixture was
poured into distilled water and extracted with DCM and
water. The combined organic phases were dried over
4-[N,N-Bis(5-(N,N-diphenylamino)-2-thienyl)amino]benzal-
dehyde (5a)
anhydrous MgSO4 and concentrated using
a rotary
In a 100 mL two-neck round-bottom flask, 4-[N,N-bis(4-
iodophenyl)amino]benzaldehyde (4) (1.05 g , 2.0 mmol),
PdCl2(PPh3)2 (24 mg, 0.034 mmol) were dissolved in 34 mL
dry dimethylformamide (DMF). The mixture was heated to
50 °C. 3a (12.0 mL, 6.0 mmol) diluted by DMF was added.
The solution was slowly warmed to 80 °C and stirred for 1 h.
The mixture was stirred for an additional 16 h at 60 °C.
After cooling, the mixture was quenched with water (2 mL)
evaporator. The residue was purified by column
chromatography on silica (petroleum ether/dichloromethane,
v/v = 2:1) to afford 40 mg of product as a yellow powder
1
(yield: 31 %). H NMR (400 MHz, CDCl3) δ (TMS, ppm):
8.74 (d, J = 8.3 Hz, 6H), 7.68 (d, J = 8.4 Hz, 6H), 7.44 (dd,
J = 14.0, 8.6 Hz, 18H), 7.29 (s, 6H), 7.26 (s, 18H), 7.18 (d,
J = 7.7 Hz, 24H), 7.14–7.01 (m, 42H), 6.66 (d, J = 3.8 Hz,